Indication
Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Loading your page…
Loading your page…
Diabetes Mellitus
Marketing Authorisation Holder: Novo Nordisk A/S
EMA Authorisation: 09/01/2017
INN: insulin aspart
AI Drug & Interaction Analysis
Free account required
Ask Osler about Fiasp: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.